ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0733

Effect of Pediatric CKD on Neurobiology and Brain Iron Deposition

Session Information

Category: Pediatric Nephrology

  • 1900 Pediatric Nephrology

Authors

  • Steinbach, Emily JS, University of Iowa Health Care, Iowa City, Iowa, United States
  • Harshman, Lyndsay, University of Iowa Health Care, Iowa City, Iowa, United States
Background

Pediatric chronic kidney disease (CKD) is associated with various systemic complications, including neurodevelopmental deficits and disturbances in iron metabolism. Our previous studies in children with CKD found increases in brain iron deposition by T2*-weighted magnetic resonance imaging (MRI). Excess iron accumulation can lead to oxidative damage in neurons and may be a key mediator of neurobehavioral deficits. However, no in vivo studies have recapitulated this “kidney-brain” phenotype and investigated the association between brain iron metabolism and behavioral outcomes.

Methods

Renal hypoplasia mice (Tg(Meox1-nucTagRFP), n=9) and controls (n=8) underwent brain MRI on a small animal 7T scanner at 10 weeks. T2* MRI maps were conducted using median filter and curve fitting with four acquired T2*-weighted echoes. Image processing was performed with the Functional MRI of the Brain Diffusion toolbox. Locomotor activity was assessed by rotarod and open field tests (OFT). Brain tissues were harvested for neuropathology and Perls Prussian blue iron staining. Unpaired t-tests analyzed group differences and linear regression models were utilized to assess the impact of brain iron deposition and behavioral outcomes.

Results

Blood urea nitrogen levels were increased in mice with CKD compared to control (p<0.05). In CKD mice, shorter T2* relaxation time was associated with increased global and cerebellar iron deposition (p<0.05) with differences primarily driven by iron deposits in gray matter (p<0.05). Mice with CKD had significantly shorter total distances traveled in the OFT and rotarod (p<0.05). Shorter rotarod distance was significantly associated with increased iron deposition in the cerebellum (R2=0.88, p<0.05). Post-mortem histology also showed significantly higher positive Prussian blue staining in the brain (p<0.05) and thinner cerebellar granular layers on neuropathology (p<0.05) compared to controls.

Conclusion

CKD is associated with significant deviations in neurobiology including increased brain iron deposition by MRI, decreased locomotor activity, and abnormal cerebellar neuropathology. Increased iron deposition in the cerebellum predicted worsening locomotor outcomes. The results of this in vivo study correlate with MRI data previously seen in children and provide an opportunity to further investigate the mechanism of abnormal iron metabolism on brain development in pediatric CKD.

Funding

  • NIDDK Support

Digital Object Identifier (DOI)